The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 05, 2022
Filed:
Nov. 30, 2020
Applicants:
Medicare Pharmaceuticals Inc., Jeollabuk-do, KR;
Medicare Lc., Jeollabuk-do, KR;
Inventors:
Do Hyun Na, Seoul, KR;
Kyung Pyo Kang, Seoul, KR;
Jin Hwan Jun, Seoul, KR;
Geon Go, Seoul, KR;
Hyeon Jun Na, Seoul, KR;
Sang Jin Kang, Seoul, KR;
Young Hyun Na, Seoul, KR;
Se Jin Yoon, Seoul, KR;
Su Ji Na, Seoul, KR;
Assignees:
Medicare Pharmaceuticals Inc., Wanju-gun, KR;
MEDICARE LC., Wanju-gun, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 31/14 (2006.01); A61K 31/517 (2006.01); C07D 239/91 (2006.01); C07D 455/02 (2006.01); A61K 35/66 (2015.01);
U.S. Cl.
CPC ...
C07D 455/02 (2013.01); A61K 31/517 (2013.01); A61K 35/66 (2013.01); A61P 31/14 (2018.01); C07D 239/91 (2013.01);
Abstract
Disclosed is a composition for inhibiting the growth of virus. More particularly, the composition for inhibiting the growth of virus includes MDPX-V2021 represented by Formula 1, wherein MDPX-V2021 serves to inhibit a post-translational modification (PTM) stage in cells after SARS-CoV-2 penetrates into the body.